Jewish Hospital Recognizes American Heart Month by Lighting Building Red
Louisville, KY (February 1, 2012)—Jewish Hospital is proud to draw awareness to cardiovascular disease, the number one killer of Americans, during the month of February by lighting their Rudd Heart & Lung Building red during the month of February. A national leader in heart care, Jewish Hospital has pioneered a number of medical firsts, including the state’s first adult heart transplant, the world’s first and second AbioCor™ implantable artificial heart surgeries and the world’s first trial of cardiac stem cells in chronic heart failure.
Jewish Hospital is pleased to not only be a leader in the treatment of heart disease, but also in the awareness and prevention of it.
“Many people do not realize that heart disease is our nation’s leading cause of death among both men and women,” said Doug Howell, interim president & CEO of the Jewish Hospital Medical Campus. “Heart disease is often preventable by having a healthy lifestyle with exercise and the proper diet. We are proud to support the American Heart Association in its efforts to help build healthier lives.”
Each year since 1963, Congress has asked the President to declare February as “American Heart Month.” One way the American Heart Association has asked organizations to draw awareness to this important health initiative is by lighting their buildings red during February.
Jewish Hospital will also provide tips for leading a heart healthy lifestyle via Facebook and Twitter throughout the month of February. Visit us at: Facebook.com/jewishhospital or Twitter.com/jewishhospital.
About Jewish Hospital
Jewish Hospital is an internationally renowned high-tech tertiary referral center developing leading-edge advancements in hand and microsurgery, heart and lung care, home care, rehab medicine (including sports medicine), orthopaedics, neuroscience, occupational health, organ transplantation and outpatient and primary care. Site of the world’s first successful hand transplant, the world’s first and second successful AbioCor® Implantable Replacement Heart procedures, and world’s first trial of cardiac stem cells in chronic heart failure, the hospital is also federally designated to perform all five solid organ transplants – heart, lung, liver, kidney and pancreas.